Clinical Trials Browser

Terminated × Lymphoma, Non-Hodgkin × 30 days × Clear all

NCT05605119 2026-04-17

SURYA-1

Phase 1 Terminated

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT05607199 2026-04-17

BHARAT-1

Phase 1 Terminated

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06761586 2026-04-17

VIJAY-1

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06088654 2026-04-14

Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma

Phase 1/2 Terminated

Lymphoma, Non-Hodgkin

NCT04853329 2026-04-09

Dose Escalation and Expansion Study of CPO107 for Patients With Advanced CD20-positive Non-Hodgkins Lymphoma

Phase 1 Terminated

Lymphoma, Non-Hodgkin

NCT05618366 2026-04-02

Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma

Phase 1 Terminated

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT04903197 2026-04-01

Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma

Phase 1 Terminated

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell